BioRestorative Therapies BRTX Q4 2025 Annual earnings
Reported March 26, 2026 · Before market open
Revenue$20.0KMiss by $130.0K
EPS-$0.37In line
Revenue estimate$150.0K
EPS estimate-$0.37
Next report
Aug 11, 2026 (In 1 week)Revenue estimate$600.0K
EPS estimate-$0.15
Versus estimates
Revenue
Ask the moment BioRestorative Therapies reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did BioRestorative Therapies report Q4 2025 earnings?
- BioRestorative Therapies (BRTX) reported Q4 2025 earnings on March 26, 2026 before market open.
- What were BioRestorative Therapies's Q4 2025 revenue and EPS?
- BioRestorative Therapies reported revenue of $20.0K and eps of $-0.37 for Q4 2025.
- Did BioRestorative Therapies beat estimates in Q4 2025?
- Revenue missed the consensus estimate of $150.0K by $130.0K. EPS beat the consensus estimate of $-0.37 by $0.00.
- How did BioRestorative Therapies's Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 53.8% from $43.3K a year earlier and eps declined 85.0% from $-0.20.
- Where can I find BioRestorative Therapies's Q4 2025 SEC filings?
- You can read the 10-K periodic report (0001493152-26-012925) directly on SEC EDGAR. The filing index links above go to sec.gov.